Weekly type 2 diabetes jab could replace daily injections

• Weekly insulin injections (icodec) offer potential to improve adherence by reducing dosing frequency from daily to once-weekly for type 2 diabetes patients
• Hundreds of thousands of patients could benefit from this treatment option, suggesting significant NHS population health implications
• Weekly formulation may enhance quality of life and treatment satisfaction compared to current daily insulin regimens, potentially reducing injection burden and associated anxiety

Hundreds of thousands of people with type 2 diabetes could get access to a new weekly insulin jab to replace daily injections.

ClinicaliQ summarises and contextualises external updates for clinical awareness, then links to the original publisher for the full article and most current context.